- Home
- ARTL vs XWEL Comparison
ARTL vs XWEL Comparison
Compare ARTL & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- XWEL
- Stock Information
- Founded
- ARTL 2011
- XWEL 2006
- Country
- ARTL United States
- XWEL United States
- Employees
- ARTL N/A
- XWEL N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- ARTL Health Care
- XWEL Consumer Discretionary
- Exchange
- ARTL Nasdaq
- XWEL Nasdaq
- Market Cap
- ARTL 3.6M
- XWEL 4.1M
- IPO Year
- ARTL N/A
- XWEL N/A
- Fundamental
- Price
- ARTL $0.95
- XWEL $0.79
- Analyst Decision
- ARTL Strong Buy
- XWEL
- Analyst Count
- ARTL 2
- XWEL 0
- Target Price
- ARTL $5.50
- XWEL N/A
- AVG Volume (30 Days)
- ARTL 1.2M
- XWEL 86.6K
- Earning Date
- ARTL 05-12-2025
- XWEL 04-15-2025
- Dividend Yield
- ARTL N/A
- XWEL N/A
- EPS Growth
- ARTL N/A
- XWEL N/A
- EPS
- ARTL N/A
- XWEL N/A
- Revenue
- ARTL N/A
- XWEL $33,897,000.00
- Revenue This Year
- ARTL N/A
- XWEL N/A
- Revenue Next Year
- ARTL N/A
- XWEL N/A
- P/E Ratio
- ARTL N/A
- XWEL N/A
- Revenue Growth
- ARTL N/A
- XWEL 12.58
- 52 Week Low
- ARTL $0.82
- XWEL $0.70
- 52 Week High
- ARTL $1.59
- XWEL $2.70
- Technical
- Relative Strength Index (RSI)
- ARTL 50.27
- XWEL 39.58
- Support Level
- ARTL $0.82
- XWEL $0.70
- Resistance Level
- ARTL $1.40
- XWEL $0.88
- Average True Range (ATR)
- ARTL 0.11
- XWEL 0.13
- MACD
- ARTL 0.02
- XWEL -0.01
- Stochastic Oscillator
- ARTL 23.10
- XWEL 23.08
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.